Kelly Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-22
Closed -$3.01K 256
2024
Q2
$3.01K Hold
22
﹤0.01% 548
2024
Q1
$2.93K Hold
22
﹤0.01% 556
2023
Q4
$3.03K Hold
22
﹤0.01% 537
2023
Q3
$2.68K Hold
22
﹤0.01% 523
2023
Q2
$3.09K Hold
22
﹤0.01% 508
2023
Q1
$3.11K Hold
22
﹤0.01% 477
2022
Q4
$3.44K Hold
22
﹤0.01% 448
2022
Q3
$2.7K Hold
22
﹤0.01% 471
2022
Q2
$2.93K Hold
22
﹤0.01% 463
2022
Q1
$3.01K Hold
22
﹤0.01% 484
2021
Q4
$3.81K Hold
22
﹤0.01% 477
2021
Q3
$3.2K Hold
22
﹤0.01% 471
2021
Q2
$2.9K Hold
22
﹤0.01% 475
2021
Q1
$2.82K Hold
22
﹤0.01% 469
2020
Q4
$2.62K Hold
22
﹤0.01% 440
2020
Q3
$2.52K Hold
22
﹤0.01% 410
2020
Q2
$2.51K Hold
22
﹤0.01% 408
2020
Q1
$1.77K Hold
22
﹤0.01% 398
2019
Q4
$2.35K Hold
22
﹤0.01% 392
2019
Q3
$2.35K Hold
22
﹤0.01% 382
2019
Q2
$2.24K Hold
22
﹤0.01% 371
2019
Q1
$1.98K Buy
+22
New +$1.91K ﹤0.01% 374

Other funds holding DGX

Kelly Financial Services's DGX Position: Q3 2024 in Review

Kelly Financial Services sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 22 shares — an estimated $3.01K sold.

Kelly Financial Services first reported a position in DGX in Q1 2019 and held it in 22 quarters. The position peaked at $3.81K in Q4 2021. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Kelly Financial Services reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 22 Quest Diagnostics shares in Q3 2024, an estimated $3.01K.
  • Kelly Financial Services first reported a position in Quest Diagnostics in Q1 2019 and held it in 22 quarters.
  • Kelly Financial Services's Quest Diagnostics position peaked at $3.81K in Q4 2021.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.